Manufacturers looking to optimise access for their orphan drugs need to navigate a complex environme...
Read moreWe're thrilled to announce our participation at World Orphan Drug Congress Europe 2024 in Barcelona ...
Read moreSpain seeks to enhance financing for orphan drug access, signalling a push for better timelines and ...
Read moreTibsovo (ivosidenib) has been granted a major additional benefit rating for its use as a first-line ...
Read moreWebinar: Our experts discuss Orphan medicine market access in Europe including the impact of EU HTA ...
Read moreThis article explores the new EU pharmaceutical package and criteria of high unmet medical need (HUM...
Read moreThis article explores the significant disparities between the US and Europe regarding orphan drugs a...
Read moreOur client required focused payer value messages for their PUMA product as payers were not recognizi...
Read moreOur client needed to understand the clinical and economic evidence requirements that drive payer dec...
Read moreOur client required focused payer value messages for their orphan drug as payers were not recognizin...
Read more